Your Unread Messages in PsychiatrySee All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
The Smartest Rheumatologist is Live: Play Now!
MDLinx Clinical Trials Navigator
See all existing trials in your area with MDLinx Clinical Trials Navigator
Many doctors expect to change jobs soon
Cause of regression in individuals with Down syndrome identified
Top Medical News
View the latest Medical News and Headlines from this week.
MDLinx Conference Center
Plan your Conference Calendar for the Summer
1 Effects of 10 to 30 years of lithium treatment on kidney function Journal of Psychopharmacology, March 23, 2015
2 Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial Journal of the Formosan Medical Association, April 3, 2015
3 Tea consumption and the risk of depression: A meta-analysis of observational studies Australian and New Zealand Journal of Psychiatry, March 30, 2015 Evidence Based Medicine
4 Risk of autistic disorder after exposure to general anaesthesia and surgery: A nationwide, retrospective matched cohort study European Journal of Anaesthesiology, April 10, 2015
5 Birth weight and obstetric complications determine age at onset in first episode of psychosis Journal of Psychiatric Research, April 8, 2015
6 Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood European Journal of Paediatric Neurology, April 7, 2015
7 The use of ketamine as an antidepressant: A systematic review and meta-analysis Human Psychopharmacology: Clinical and Experimental, April 13, 2015 Evidence Based Medicine
8 Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial Journal of Psychopharmacology, April 6, 2015
9 Fronto-parietal activation during response inhibition predicts remission to antidepressants in patients with major depression Biological Psychiatry, April 2, 2015
10 A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder Neuropsychopharmacology, April 6, 2015
2015 © M3 USA. ALL Rights Reserved.